Back to News
Market Impact: 0.05
Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Source: globenewswire.com
Healthcare & Biotech
Prelude Therapeutics announced it will participate in the Chardan Healthcare Conference in New York City on October 20, 2026. The announcement provides no financial results, guidance, or other material updates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Yields continue to rattle investors. These sectors are most at risk if rates stay elevated
- After years of U.S. export bans, China plans its own: 40 AI, chip and solar technologies could be restricted
- MapLight Therapeutics CMO Erin Foff sells $124,068 in stock
- William Blair initiates Revolution stock with outperform on RAS franchise
- Sickle cell gene therapies offer new hope, but access remains a major challenge
- FDA approves Enspryng for thyroid eye disease treatment
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Alternative Data Due Diligence for Institutional Investors
- Introducing AllMind: A New Data & AI Workspace for Institutional Investors